The emergence of Retatrutide ZPHC, at a strength of 120mg, is sparking considerable buzz within the healthcare community. This novel dual GIP and GLP-1 agonist medication suggests to deliver impressive improvements in fat loss compared to existing therapies. Initial research studies have shown significant declines in weight , potentially representi